Group One Trading, L.P. Bluebird Bio, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 321,655 shares of BLUE stock, worth $131,878. This represents 0.01% of its overall portfolio holdings.
Number of Shares
321,655
Previous 522,659
38.46%
Holding current value
$131,878
Previous $669,000
52.91%
% of portfolio
0.01%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding BLUE
# of Institutions
159Shares Held
79.5MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$6.33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$4.22 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$2.62 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.11 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.91 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $31.6M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...